Tandem Diabetes Care, Inc. (LON:0M0F)
21.61
+0.42 (1.96%)
At close: Dec 15, 2025
Tandem Diabetes Care Employees
Tandem Diabetes Care had 2,650 employees as of December 31, 2024. The number of employees increased by 250 or 10.42% compared to the previous year.
Employees
2,650
Change (1Y)
250
Growth (1Y)
10.42%
Revenue / Employee
282.70K GBP
Profits / Employee
-57.09K GBP
Market Cap
1.12B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2,650 | 250 | 10.42% |
| Dec 31, 2023 | 2,400 | -200 | -7.69% |
| Dec 31, 2022 | 2,600 | 600 | 30.00% |
| Dec 31, 2021 | 2,000 | 500 | 33.33% |
| Dec 31, 2020 | 1,500 | 457 | 43.82% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| HSBC Holdings | 211,304 |
| Unilever | 115,964 |
| BP p.l.c. | 100,500 |
| Shell | 96,000 |
| AstraZeneca | 94,300 |
| Barclays | 93,000 |
| GSK plc | 68,629 |
| Rio Tinto Group | 60,000 |